Table 1.
Pros | |
Non-invasive method | |
Easily repeatable | |
Monitoring for early detection of mutation onset in the ALK gene | |
Alternative approach to a tissue biopsy when: Presence of a non-biopsiable tumor site Patient is fragile Presence of a weak percentage of tumor cells Poor quality of extracted RNA |
|
Cons | |
ALK status assessment in circulating tumor cells is not available routinely | |
The quality of the results is strongly related to some pre analytical parameters: Volume of blood sample Tubes used for blood collection Delay for transfer to the laboratory Centrifugation procedure Temperature of plasma/platelets storage |
|
Large variability of amount of CTCs and free tumor RNA and platelets associated tumor RNA according to the patient |